Related Experiment Video
Updated: Jun 28, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Identification of novel mutations in five patients with mitochondrial encephalomyopathy
Lucia Valente1, Daniela Piga, Eleonora Lamantea
1IRCCS Foundation Neurological Institute C. Besta, Milan, Italy.
Abstract:
MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNA(Trp) and tRNA(Phe), respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders.
Insights
Mitochondrial DNA (mtDNA) sequencing identified novel mutations in patients with neuromuscular syndromes. This suggests broader genetic testing is crucial for diagnosing mitochondrial disorders.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Established mitochondrial syndromes like MELAS, MERRF, LHON, and NARP are linked to specific mitochondrial DNA (mtDNA) point mutations.
- These known mutations explain only a fraction of mitochondrial disease cases, highlighting the need to investigate other genetic causes.
Purpose of the Study:
- To investigate the impact of novel mtDNA mutations in patients with mitochondrial neuromuscular syndromes.
- To identify and characterize new genetic variations within the mtDNA that contribute to disease.
Main Methods:
- Mitochondrial DNA sequence analysis was performed on muscle and other tissues from 240 patients.
- Clinical, biochemical, and molecular genetic data were collected and analyzed for individuals with identified mutations.
Main Results:
- Thirty-three subjects with novel, private, or uncommon mtDNA mutations were identified.
- Five novel mutations were found in both pediatric and adult patients, affecting genes like ND, COI, and tRNAs (tRNA(Trp), tRNA(Phe)).
Conclusions:
- Novel mtDNA mutations are present in a significant number of patients with mitochondrial neuromuscular syndromes.
- mtDNA analysis should be integrated into routine screening protocols for diagnosing mitochondrial disorders.
More Related Videos
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Published on: November 23, 2011
07:24Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondrial Membranes
Mitochondrial Membranes